Rh sensitization during pregnancy
Rh sensitization is the process by which the
Rh-negative mother's
immune system reacts to her fetus's Rh-positive blood.
After fetal blood enters the mother's blood system, her immune system produces
antibodies that destroy Rh-positive red blood cells.
Sensitization most commonly occurs during childbirth. About 90% of
women who become sensitized do so at delivery, when maternal blood is most
likely to mix with fetal blood.1
About 17% of Rh-negative women who do not receive Rh
immune globulin will become sensitized during
pregnancy or childbirth.2 The minimum amount of
blood mixing necessary to cause sensitization is not known. But some women
who become sensitized do so after becoming exposed to as little as
0.1 mL of Rh-positive blood.2
Rh sensitization can almost always be prevented with an Rh immune
globulin injection during pregnancy and after delivery. Of women who get Rh
immune globulin, less than 1% will become sensitized.3
Some women do not become sensitized even though they are exposed to
large amounts of Rh-positive blood. The reason for this is not known.
Sensitization usually does not affect fetal health during the newly
sensitized pregnancy. But an Rh-positive fetus in a subsequent pregnancy
can be severely affected.
Citations
-
Hartwell EA (1998). Use of Rh immune globulin: ASCP
practice parameter. American Journal of Clinical Pathology, 110(3): 281–292.
-
American College of Obstetricians and Gynecologists
(1999, reaffirmed 2007). Prevention of Rh D alloimmunization. ACOG Practice Bulletin No. 4.
Obstetrics and Gynecology, 93(5):
1–7.
-
Moise KJ (2009). Hemolytic disease of the fetus and
newborn. In RK Creasy, R Resnik, eds., Creasy and Resnik's Maternal-Fetal Medicine, 6th ed., pp. 477–503. Philadelphia:
Saunders Elsevier.
Last Updated:
October 22, 2009
Hartwell EA (1998). Use of Rh immune globulin: ASCP
practice parameter. American Journal of Clinical Pathology, 110(3): 281–292.
American College of Obstetricians and Gynecologists
(1999, reaffirmed 2007). Prevention of Rh D alloimmunization. ACOG Practice Bulletin No. 4.
Obstetrics and Gynecology, 93(5):
1–7.
Moise KJ (2009). Hemolytic disease of the fetus and
newborn. In RK Creasy, R Resnik, eds., Creasy and Resnik's Maternal-Fetal Medicine, 6th ed., pp. 477–503. Philadelphia:
Saunders Elsevier.